Research programme: single chain T cell receptors - Sunol Molecular
Latest Information Update: 08 May 2008
At a glance
- Originator Sunol Molecular Corporation
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 17 May 2005 No development reported - Preclinical for Cancer in USA (unspecified route)
- 09 Jul 2002 Preclinical trials in Cancer in USA (unspecified route)